Sapio Sciences Helps a Biotech Prepare for “What Comes After Terabytes?”
Sapio Sciences Helps a Biotech Prepare for “What Comes After Terabytes?”
3 PagesA biotech company developing personalized cell therapies adopted the Sapio Platform in 2023 to manage rapidly expanding data demands. Using Sapio LIMS and ELN in a unified system, the organization launched a three‑phase integration plan. Phase 1 focused on automating dynamic experimental workflows, tracking all sample details, and integrating data with ELNs. Phase 2 aims to support translational science, while Phase 3 will address the challenges of scaling beyond terabytes, ensuring the company can manage and utilize its growing data effectively.
